SIBN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SI-BONE Inc (SIBN) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company has strong analyst support, positive revenue growth, and a strategic partnership with Smith & Nephew, which enhances its market position. Despite a slight pre-market price drop and insider selling, the overall outlook remains positive for long-term growth.
The MACD is positive and expanding, indicating bullish momentum. However, the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting a short-term downtrend. RSI is neutral at 68.158, and the stock is trading near its resistance level (R1: 16.521). Key support is at 15.78.
Record Q4 2025 earnings with 15% YoY revenue growth.
Strategic partnership with Smith & Nephew for trauma solutions.
Multiple analysts raised price targets, with a consensus Buy rating.
Hedge funds are significantly increasing their positions.
Insider selling has increased by 260.86% over the last month.
Net income and EPS have dropped significantly YoY.
Slight pre-market price decline (-0.86%).
In Q4 2025, revenue increased by 14.99% YoY to $56.35M. However, net income dropped by 63.43% YoY to -$1.64M, and EPS declined by 63.64% to -$0.04. Gross margin slightly decreased to 79.03%.
Analysts maintain a Buy rating with raised price targets ranging from $21 to $27. They highlight strong growth potential, a unique business model, and progress toward profitability.
